Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18360 | 490 | 30.0 | 41% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TUFTSIN | Author keyword | 34 | 55% | 9% | 42 |
2 | KENTSIN | Author keyword | 6 | 100% | 1% | 4 |
3 | NOR MURAMYL DIPEPTIDE | Author keyword | 3 | 100% | 1% | 3 |
4 | TUFTSIN DERIVATIVES | Author keyword | 2 | 67% | 0% | 2 |
5 | GLYCOSYLATED TUFTSIN | Author keyword | 1 | 100% | 0% | 2 |
6 | NOR MDP | Author keyword | 1 | 100% | 0% | 2 |
7 | RETRO TUFTSIN | Author keyword | 1 | 50% | 0% | 2 |
8 | RIGIN | Author keyword | 1 | 100% | 0% | 2 |
9 | TETRAPEPTIDE ARG PRO GLY PRO | Author keyword | 1 | 100% | 0% | 2 |
10 | TUFTSIN ANALOG | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUFTSIN | 34 | 55% | 9% | 42 | Search TUFTSIN | Search TUFTSIN |
2 | KENTSIN | 6 | 100% | 1% | 4 | Search KENTSIN | Search KENTSIN |
3 | NOR MURAMYL DIPEPTIDE | 3 | 100% | 1% | 3 | Search NOR+MURAMYL+DIPEPTIDE | Search NOR+MURAMYL+DIPEPTIDE |
4 | TUFTSIN DERIVATIVES | 2 | 67% | 0% | 2 | Search TUFTSIN+DERIVATIVES | Search TUFTSIN+DERIVATIVES |
5 | GLYCOSYLATED TUFTSIN | 1 | 100% | 0% | 2 | Search GLYCOSYLATED+TUFTSIN | Search GLYCOSYLATED+TUFTSIN |
6 | NOR MDP | 1 | 100% | 0% | 2 | Search NOR+MDP | Search NOR+MDP |
7 | RETRO TUFTSIN | 1 | 50% | 0% | 2 | Search RETRO+TUFTSIN | Search RETRO+TUFTSIN |
8 | RIGIN | 1 | 100% | 0% | 2 | Search RIGIN | Search RIGIN |
9 | TETRAPEPTIDE ARG PRO GLY PRO | 1 | 100% | 0% | 2 | Search TETRAPEPTIDE+ARG+PRO+GLY+PRO | Search TETRAPEPTIDE+ARG+PRO+GLY+PRO |
10 | TUFTSIN ANALOG | 1 | 100% | 0% | 2 | Search TUFTSIN+ANALOG | Search TUFTSIN+ANALOG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LYS PRO ARG | 22 | 81% | 3% | 13 |
2 | PHAGOCYTOSIS STIMULATING PEPTIDE | 18 | 67% | 3% | 16 |
3 | IMMUNOPHARMACOLOGICAL PROPERTIES | 11 | 100% | 1% | 6 |
4 | DRUG VEHICLES | 7 | 57% | 2% | 8 |
5 | TUFTSIN | 6 | 28% | 4% | 18 |
6 | STIMULATING PEPTIDE TUFTSIN | 6 | 100% | 1% | 4 |
7 | BEARING LIPOSOMES | 5 | 43% | 2% | 9 |
8 | IMMUNOMODULATING PEPTIDE | 3 | 60% | 1% | 3 |
9 | GLYCOSYLATED TUFTSINS | 2 | 67% | 0% | 2 |
10 | MURAMYLPEPTIDES | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tuftsin: On the 30-year anniversary of Victor Najjar's discovery | 1999 | 53 | 228 | 62% |
Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections | 2005 | 18 | 12 | 92% |
TUFTSIN - ITS CHEMISTRY, BIOLOGY, AND CLINICAL POTENTIAL | 1989 | 74 | 84 | 79% |
Tuftsin-bearing liposomes in treatment of macrophage-based infections | 2000 | 49 | 64 | 23% |
Tuftsin and Tuftsin analogs: Biology, synthesis and design theory | 1996 | 2 | 70 | 87% |
IMMUNOGLOBULIN-DERIVED DRUGS | 1986 | 9 | 2 | 100% |
BIOLOGICAL-ACTIVITIES RESIDING IN THE FC REGION OF IMMUNOGLOBULIN | 1987 | 56 | 122 | 30% |
TUFTSIN - AN IMMUNOMODULATING PEPTIDE-HORMONE AND ITS CLINICAL POTENTIAL AS A NATURAL BIOLOGICAL RESPONSE MODIFIER | 1984 | 13 | 31 | 65% |
PEPTIDE-HORMONES AS PROHORMONES | 1986 | 23 | 11 | 18% |
LYMPHOCYTE-ACTIVATION BY THE FC REGION OF IMMUNOGLOBULINS | 1986 | 8 | 89 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL EXPTL THER Y | 1 | 50% | 0.2% | 1 |
2 | INTER DISCIPLINARY BIOTECHNOL UNIT | 1 | 50% | 0.2% | 1 |
3 | INTER ES NANOSTRUCT | 1 | 17% | 0.6% | 3 |
4 | PROT INFORMAT TECHNOL GRP | 0 | 20% | 0.4% | 2 |
5 | BLOOD PROTECT SYST | 0 | 33% | 0.2% | 1 |
6 | HIST IMMUNOL | 0 | 33% | 0.2% | 1 |
7 | MTA ELTE GRP PEPTIDE CHEM | 0 | 18% | 0.4% | 2 |
8 | STATE VET MED AGR ECON | 0 | 17% | 0.4% | 2 |
9 | ALTAREX CORP | 0 | 25% | 0.2% | 1 |
10 | CLIN MICROBIOL ANTIMICROBIAL THER Y | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000091457 | FC GAMMA RECEPTOR EXPRESSION//TRIANTHEMA PORTULACASTRUM//CELL BIOL INJURY SCI |
2 | 0.0000088772 | ASSOCIATIVE CONNECTIONS//INTERCENTRAL RELATIONS//RAT BRAIN NEURONS |
3 | 0.0000076631 | PEPTIDOGLYCAN MONOMER//ROMURTIDE//MURAMYL DIPEPTIDE |
4 | 0.0000071827 | BIOL CELLULAIRE EXPT//ADHERING CELLS//EP 89 |
5 | 0.0000061366 | FC GAMMA RECEPTORS//FC RECEPTOR//FC GAMMA RIIA |
6 | 0.0000054572 | HYPOSPLENISM//CAVITATING MESENTERIC LYMPH NODE SYNDROME//LYMPH NODE CAVITATION |
7 | 0.0000051650 | 15S 15 METHYLPROSTAGLANDIN F 2 ALPHA METHYL ESTER//NON SYNCHRONOUS SHIFT//PARTIAL EXTRACT WITHDRAWAL |
8 | 0.0000049700 | MS14//CD4 MESSENGER RNA//IMMUNOL 332 N LAUDERDALE POB 318 |
9 | 0.0000043537 | LACTONAMYCIN//ANTIPARKINSONISM//NEW REACTIONS |
10 | 0.0000040201 | IMEXON//1 4 DIHYDRO 2 3 QUINOXALINEDIONE//CYANOAZIRIDINE |